← Back to headlines
Goldman-Backed Attovia Therapeutics Raises $289 Million in US IPO
Attovia Therapeutics Inc., an early-stage biotech company focused on immune system diseases, successfully raised $289 million in its US initial public offering, pricing shares at the top of its marketed range.
5 Aug, 01:06 — 5 Aug, 01:06
